These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36471176)

  • 1. Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview.
    Ratre P; Kulkarni S; Das S; Liang C; Mishra PK; Thareja S
    Med Oncol; 2022 Dec; 40(1):41. PubMed ID: 36471176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advancement in nonsteroidal aromatase inhibitors for treatment of estrogen-dependent breast cancer.
    Jiao J; Xiang H; Liao Q
    Curr Med Chem; 2010; 17(30):3476-87. PubMed ID: 20738251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of coumarin derivatives in pharmacotherapy of breast cancer.
    Musa MA; Cooperwood JS; Khan MO
    Curr Med Chem; 2008; 15(26):2664-79. PubMed ID: 18991629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and biological characterization of a novel anti-aromatase coumarin derivative.
    Chen S; Cho M; Karlsberg K; Zhou D; Yuan YC
    J Biol Chem; 2004 Nov; 279(46):48071-8. PubMed ID: 15358790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of synthesized coumarin derivatives on aromatase inhibitory activity.
    Yamaguchi Y; Nishizono N; Kobayashi D; Yoshimura T; Wada K; Oda K
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2645-2649. PubMed ID: 28512028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
    Ahmad I; Shagufta
    Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in study of the structure, catalytic mechanism and inhibitors of aromatase].
    Fu J; Shen ZH; Cheng FX; Liu GX; Li WH; Tang Y
    Yao Xue Xue Bao; 2012 Jan; 47(1):18-28. PubMed ID: 22493800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors.
    Adhikari N; Baidya SK; Jha T
    Eur J Med Chem; 2020 Dec; 208():112845. PubMed ID: 33017749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase inhibitors for the treatment of breast cancer: An overview (2019-2023).
    Bhatia N; Thareja S
    Bioorg Chem; 2024 Oct; 151():107607. PubMed ID: 39002515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on diverse heterocyclic compounds as the privileged scaffolds in non-steroidal aromatase inhibitors.
    Rani S; Raheja K; Luxami V; Paul K
    Bioorg Chem; 2021 Aug; 113():105017. PubMed ID: 34091288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic and natural coumarins as potent anticonvulsant agents: A review with structure-activity relationship.
    Keri RS; Budagumpi S; Balappa Somappa S
    J Clin Pharm Ther; 2022 Jul; 47(7):915-931. PubMed ID: 35288962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds.
    Stefanachi A; Leonetti F; Pisani L; Catto M; Carotti A
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29382051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase.
    Stefanachi A; Favia AD; Nicolotti O; Leonetti F; Pisani L; Catto M; Zimmer C; Hartmann RW; Carotti A
    J Med Chem; 2011 Mar; 54(6):1613-25. PubMed ID: 21341743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer.
    Yadav MR; Barmade MA; Tamboli RS; Murumkar PR
    Eur J Med Chem; 2015 Nov; 105():1-38. PubMed ID: 26469743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibitors in the treatment of breast cancer.
    Brueggemeier RW; Hackett JC; Diaz-Cruz ES
    Endocr Rev; 2005 May; 26(3):331-45. PubMed ID: 15814851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Synthesized Ester or Amide Coumarin Derivatives on Aromatase Inhibitory Activity.
    Yamaguchi Y; Nishizono N; Oda K
    Biol Pharm Bull; 2020; 43(8):1179-1187. PubMed ID: 32741938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Journey and Recent Advances in the Synthesis of Coumarin Derivatives.
    Sinha S; Singh K; Ved A; Hasan SM; Mujeeb S
    Mini Rev Med Chem; 2022; 22(9):1314-1330. PubMed ID: 34784861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase Inhibitors for the Treatment of Breast Cancer: A Journey from the Scratch.
    Ratre P; Mishra K; Dubey A; Vyas A; Jain A; Thareja S
    Anticancer Agents Med Chem; 2020; 20(17):1994-2004. PubMed ID: 32593281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconsidering Aromatase for Breast Cancer Treatment: New Roles for an Old Target.
    Caciolla J; Bisi A; Belluti F; Rampa A; Gobbi S
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33207783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase inhibitors and breast cancer.
    Miller WR
    Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.